Press Releases
2019-11-06 // CALIXAR and COSMO BIO to conclude distribution agreement
2019-05-20 // Biotem enters into collaboration with Calixar for the development of therapeutic antibodies against membrane protein targets
2019-04-29 // Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target
2019-04-05 // Calixar announces a collaborative research agreement with Thermo Fisher Scientific on multiple membrane proteins of high relevance to drug discovery
2017-11-28 // CALIXAR and ASTRAZENECA to publish new insight on KCC2 architecture and function in Scientific Reports
2016-06-24 // CALIXAR and University of Avignon to launch new research lab developing innovative chemistry for target discovery
2015-12-04 // CALIXAR and Biouniversa to publish unprecedented new insights on Pancreatic Ductal Adenocarcinoma (PDAC) in Nature Communications
2015-02-23 // CALIXAR raises €1 Million
2014-10-20 // CALIXAR and ASTON University collaboration on multidrug resistance targets
2014-09-23 // Major Breakthrough in Influenza Vaccines
2014-06-16 // New Strategic Compounds
2014-06-16 // CALIXAR to extend its portfolio of strategic compounds for complex pharmaceutical target isolation
2013-10-01 // ABL Strategic Marketing
2012-06-18 // CALIXAR closes an initial €875,000 funding round